- Home
- AVIR vs RCAT Comparison
AVIR vs RCAT Comparison
Compare AVIR & RCAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVIR
- RCAT
- Stock Information
- Founded
- AVIR 2012
- RCAT 2002
- Country
- AVIR United States
- RCAT United States
- Employees
- AVIR N/A
- RCAT N/A
- Industry
- AVIR Medicinal Chemicals and Botanical Products
- RCAT Wholesale Distributors
- Sector
- AVIR Health Care
- RCAT Industrials
- Exchange
- AVIR Nasdaq
- RCAT Nasdaq
- Market Cap
- AVIR 276.9M
- RCAT 248.8M
- IPO Year
- AVIR 2020
- RCAT 2017
- Fundamental
- Price
- AVIR $3.25
- RCAT $7.30
- Analyst Decision
- AVIR Hold
- RCAT Strong Buy
- Analyst Count
- AVIR 1
- RCAT 1
- Target Price
- AVIR $6.88
- RCAT $4.00
- AVG Volume (30 Days)
- AVIR 178.7K
- RCAT 3.6M
- Earning Date
- AVIR 11-07-2024
- RCAT 12-13-2024
- Dividend Yield
- AVIR N/A
- RCAT N/A
- EPS Growth
- AVIR N/A
- RCAT N/A
- EPS
- AVIR N/A
- RCAT N/A
- Revenue
- AVIR N/A
- RCAT $18,864,788.00
- Revenue This Year
- AVIR N/A
- RCAT $125.67
- Revenue Next Year
- AVIR N/A
- RCAT N/A
- P/E Ratio
- AVIR N/A
- RCAT N/A
- Revenue Growth
- AVIR N/A
- RCAT 259.85
- 52 Week Low
- AVIR $2.81
- RCAT $0.53
- 52 Week High
- AVIR $4.60
- RCAT $7.86
- Technical
- Relative Strength Index (RSI)
- AVIR 44.03
- RCAT 86.61
- Support Level
- AVIR $3.10
- RCAT $4.43
- Resistance Level
- AVIR $3.48
- RCAT $5.62
- Average True Range (ATR)
- AVIR 0.13
- RCAT 0.55
- MACD
- AVIR -0.01
- RCAT 0.35
- Stochastic Oscillator
- AVIR 29.52
- RCAT 88.55
About AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).
About RCAT Red Cat Holdings Inc.
Red Cat Holdings Inc is a military technology company that integrates robotic hardware and software to provide critical situational awareness and actionable intelligence to on-the-ground warfighters and battlefield commanders. Its mission is to enhance the effectiveness and safety of military operations domestically and globally. Red Cat's suite of solutions includes Teal Drones, developer of the Golden Eagle, a small unmanned system with the highest resolution imaging for night-time operations, and Skypersonic, a provider of unmanned aircraft for interior spaces and other dangerous environments.